Upgrade to SI Premium - Free Trial

Biohaven Pharma (BHVN) PT Lowered to $30 at Raymond James

August 26, 2026 10:17 AM
Raymond James analyst Chris Raymond lowered the price target on Biohaven Pharma (NYSE: BHVN) to $30.00 (from $50.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change